ArticleFrontiers in immunology2025

Cost-effectiveness analysis of Toripalimab regimen for extensive-stage small-cell lung cancer in China and America.

Jing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.